Originator Organization T3 Pharmaceuticals AGStartup |
Active Organization T3 Pharmaceuticals AGStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | T3 Pharmaceuticals AGStartup | 15 Apr 2022 |